MAGEA4 and synovial sarcoma: As an example, the extent of response for synovial sarcoma and myxoid round cell liposarcoma patients to MAGE-A4 TCR-T cells (afami-cel) is confounded by potential lingering cytoreductive effects of the conditioning chemotherapy [103].